HIV project

​

In this sub-project, we will first conduct research on a number of drugs that have been shown to be helpful in the treatment of AIDS patients in the work of Jeremy and Camilla Sherr. In doing so, we rely on an experimental setup with which different steps of the infection of helper cells can be mapped without having to rely on high-security laboratories. If this approach proves to be meaningful, in a next step we will examine all available individual drugs for their effects in order to identify new drugs that can be used in the treatment of HIV infections in addition to antiretroviral therapy.

​

​

Why HIV Research?

 

Worldwide, around 37 million patients are suffering from AIDS. The majority of patients live in low-income regions of the world and are therefore dependent on support for treatment . Fortunately, various efforts have resulted in 27 million of those affected receiving combination antiretroviral therapies, which significantly improve the prognosis. 

​

Our research targets the 10 million patients who do not have access to effective therapies or who  belong to the growing group infected with resistant strains and thus no longer treatable with current means. This problem will continue to increase because the HI virus is extremely adaptable and resistance develops much faster than we know from bacteria. 

​

Through the work of Jeremy and Camilla Sherr in Tanzania, who have now treated over 10,000 HIV patients alongside antiretroviral therapy, we know how well homeopathy can help patients. Our goal is to identify new effective drugs through in vitro research that can improve this treatment approach and make it accessible to a larger group of patients.